How hCGβ Affects Bladder Cancer Cells
Author Information
Author(s): Butler S A, Ikram M S, Mathieu S, Iles R K
Primary Institution: Williamson Laboratory, Department of Obstetrics and Gynecology, St Bartholomew's and the Royal London School of Medicine and Dentistry, London, EC1A 7BE, UK
Hypothesis
The ectopic production of hCGβ contributes to the radioresistance and metastatic potential of bladder carcinoma by inhibiting apoptosis.
Conclusion
The study found that hCGβ inhibits apoptosis in bladder carcinoma cells, which may explain the increased cell population and aggressive nature of these tumors.
Supporting Evidence
- Ectopic production of hCGβ occurs in approximately 35% of bladder carcinoma cases.
- hCGβ-secreting tumors are more aggressive and have a greater propensity to metastasize.
- Addition of hCGβ to cancer cell cultures increased cell populations without increasing replication rates.
- hCGβ reduced the number of apoptotic bodies in a dose-dependent manner.
Takeaway
This study shows that a substance called hCGβ helps bladder cancer cells survive longer by stopping them from dying, which might make the cancer more dangerous.
Methodology
The study used immunoassays to quantify apoptotic bodies and MTT assays to determine cell number.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website